Dapadax-M 10/500 Tablets provide an established, clinically unified combination anti-hyperglycemic therapy carefully developed for the continuous management, long-term stabilization, and comprehensive physiological protection of Type 2 Diabetes Mellitus. When standard single-mechanism options fail to address shifting HbA1c lines, targeting glycemic control across multiple distinct organ frameworks becomes critical. This advanced formulation integrates two separate, highly complementary drug classes within a single unit, working simultaneously across the renal filtration system and peripheral cell walls to maximize glucose clearance safely over a long-term care routine.
The synchronized formulation operates dynamically across two distinct metabolic fronts:
-
Dapagliflozin (10 mg): A highly selective, potent inhibitor of Sodium-Glucose Co-Transporter 2 (SGLT2) located in the proximal convoluted tubules of the kidneys. By blocking this pathway, it directly inhibits renal glucose reabsorption, lowering the renal threshold for glucose and systematically filtering excess glucose out of the body through the urine. This insulin-independent tracking reduces plasma glucose and provides an added caloric discharge.
-
Metformin HCL (500 mg ER): A foundational biguanide presented in a specialized extended-release matrix layout. It targets insulin resistance at its roots by decreasing hepatic gluconeogenesis (glucose production in the liver), lowering intestinal sugar absorption, and actively enhancing peripheral insulin sensitivity to accelerate glucose uptake across skeletal muscle structures around the clock.
Key Benefits
-
Advanced Dual Action Baseline: Unites an insulin-independent renal filter with a peripheral tissue sensitizer to maximize sugar clearing profiles.
-
Insulin-Independent Safety Track: Dapagliflozin operates entirely independently of pancreatic beta-cell status, minimizing the baseline statistical risk of sudden drops (hypoglycemia).
-
Extended-Release Digestive Cover: The specialized Metformin matrix dissolves slowly over many hours, significantly reducing tracking risks of gastrointestinal irritation.
-
Added Cardio-Renal & Weight Control: Promotes a gentle osmotic fluid reduction and caloric loss via urine, directly supporting blood pressure control and natural weight stabilization.
-
Trusted Quality Execution: Manufactured under strict pharmaceutical protocols of DH, ensuring exceptional dissolution uniformity and steady ingredient bioavailability.
Directions for Use
-
Take exactly as directed by your diabetologist, endocrinologist, or primary healthcare physician.
-
Dapadax-M 10/500 must strictly be taken orally once daily, at the exact same hour every single morning with breakfast or your first main meal. Consuming it with food optimizes Metformin tolerability.
-
Swallow the tablet whole with a full glass of plain water. Do not crush, break, split, or chew it, as doing so will instantly destroy the specialized extended-release framework and cause rapid medicine dumping.
-
Maintain complete daily consistency alongside a structured low-glycemic diet and active fluid tracking routines; missing doses can cause blood sugar parameters to drift outside boundaries.
Safety & Precautions
-
Do not alter your dose or halt usage suddenly without professional medical clearance, as blood sugar levels can rise rapidly.
-
Hydration & Euglycemic DKA Rule: Because Dapagliflozin channels glucose through the urinary tract, you must maintain a generous intake of water daily to prevent dehydration. Be aware of a rare but serious condition called Euglycemic Diabetic Ketoacidosis (DKA), where acid buildups happen even with near-normal blood sugar. Seek immediate feedback if you track severe nausea, vomiting, sudden deep breathing, or extreme fatigue.
-
Genital & Urinary Tract Infection Warning: Increased sugar concentrations in the urine create a natural environment for microbial tracking. Maintain strict personal hygiene and update your specialist if you notice persistent burning during urination, localized redness, irritation, or unusual discharge.
-
Lactic Acidosis Warning: Although rare, Metformin accumulation can trigger lactic acidosis. The risk shifts higher with heavy chronic alcohol use, severe kidney impairment, or acute dehydration. Monitor your renal function parameters (serum creatinine / eGFR) regularly.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat sources, and environmental room moisture pools.
-
Always keep the tablets safely sealed inside their original protective blister packaging layout until the exact moment of intake to shield the core components from ambient room humidity.
